Cell therapy manufacturability program

We envision Cell Therapy Manufacturability Program with defined projects within the context of the Program:

​

• Rights, roles, and responsibilities of each participating organization

• Unified donor registry

• Precompetitive legal framework definition

• Federated data architecture build

• Collection and processing standardization

• Data standardization

• Advanced IPC analytical technology development

• Advanced IPC technology deployment

• Multi-dimensional sample analysis

• Correlative algorithmic analysis

​

We envision that the support for this program will be shared between therapy developers, government funding, and disease state organizations.